Mohammad Mofidfar, Behnam Abdi, Samad Ahadian, Ebrahim Mostafavi, Tejal A. Desai, Farhang Abbasi, Yang Sun, Edward E. Manche, Christopher N. Ta & Charles W. Flowers. (2021) Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies. International Journal of Pharmaceutics 607, pages 120924.
Crossref
Tamilvanan ShunmugaperumalOly Katari & Tamilvanan Shunmugaperumal. 2020. Oil‐in‐Water Nanosized Emulsions for Drug Delivery and Targeting. Oil‐in‐Water Nanosized Emulsions for Drug Delivery and Targeting
259
285
.
Meltem Ezgi DurgunSevgi GüngörYıldız Özsoy. (2020) Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases. Journal of Ocular Pharmacology and Therapeutics 36:6, pages 323-341.
Crossref
Yıldız Özsoy, Sevgi Güngör, Emine Kahraman & M. Ezgi Durgun. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
85
117
.
Anita Patel, Jayvadan K. Patel & Yashwant V. Pathak. 2018. Drug Delivery for the Retina and Posterior Segment Disease. Drug Delivery for the Retina and Posterior Segment Disease
327
349
.
Zachary Estlack, Devasier Bennet, Ted Reid & Jungkyu Kim. (2017) Microengineered biomimetic ocular models for ophthalmological drug development. Lab on a Chip 17:9, pages 1539-1551.
Crossref
A.A. Attama, J.N. Reginald-Opara, E.M. Uronnachi & E.B. Onuigbo. 2016. Nanoscience in Dermatology. Nanoscience in Dermatology
323
336
.
Ameeduzzafar Zafar, Javed Ahmad, Sohail Akhter & Richard T. Addo. 2016. Ocular Drug Delivery: Advances, Challenges and Applications. Ocular Drug Delivery: Advances, Challenges and Applications
75
99
.
Burcin Yavuz & Uday B. Kompella. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease
57
93
.
Arun Kumar, Heidi Mansour, Adam Friedman & Eric BloughJaleh Barar & Yadollah Omidi. 2013. Nanomedicine in Drug Delivery. Nanomedicine in Drug Delivery
287
336
.
Sarah A. MolokhiaSamuel C. ThomasKevin J. GarffKenneth J. MandellBarbara M. Wirostko. (2013) Anterior Eye Segment Drug Delivery Systems: Current Treatments and Future Challenges. Journal of Ocular Pharmacology and Therapeutics 29:2, pages 92-105.
Crossref
Viral Tamboli, Sujay Shah & Ashim K. Mitra. 2013. Ocular Transporters and Receptors. Ocular Transporters and Receptors
207
228
.
Kishore Cholkar, Animikh Ray, Vibhuti Agrahari, Dhananjay Pal & Ashim K. Mitra. 2013. Ocular Transporters and Receptors. Ocular Transporters and Receptors
115
168
.
. 2012. Ocular Drug Delivery Systems. Ocular Drug Delivery Systems
318
323
.
Zhong Zuo & Vincent H. L. Lee. 2012. Chemical Biology. Chemical Biology
147
164
.
C.C. Peng, L.C. Bengani, H.J. Jung, J. Leclerc, C. Gupta & A. Chauhan. (2011) Emulsions and microemulsions for ocular drug delivery. Journal of Drug Delivery Science and Technology 21:1, pages 111-121.
Crossref
Ketan Hippalgaonkar, Ramesh Srirangam, Bharathi Avula, Ikhlas A. Khan & Soumyajit Majumdar. (2010) Interaction between Topically and Systemically Coadministered P-Glycoprotein Substrates/Inhibitors: Effect on Vitreal Kinetics. Drug Metabolism and Disposition 38:10, pages 1790-1797.
Crossref
Uday B Kompella, Rajendra S Kadam & Vincent HL Lee. (2010) Recent advances in ophthalmic drug delivery. Therapeutic Delivery 1:3, pages 435-456.
Crossref
Ripal Gaudana, Hari Krishna Ananthula, Ashwin Parenky & Ashim K. Mitra. (2010) Ocular Drug Delivery. The AAPS Journal 12:3, pages 348-360.
Crossref
Shunmugaperumal Tamilvanan. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
40
.
Shunmugaperumal Tamilvanan. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
49
.
Katragadda SureshZhu XiadongTalluri S. RaviAshim K. Mitra. (2010) Small Neutral Amino Acid Ester Prodrugs of Acyclovir Targeting Amino Acid Transporters on the Cornea: Possible Antiviral Agents against Ocular HSV-1 Infections. Ophthalmology and Eye Diseases 2, pages 117917211000200.
Crossref
Soumyajit Majumdar, Ketan Hippalgaonkar & Ramesh Srirangam. (2009) Vitreal Kinetics of Quinidine in Rabbits in the Presence of Topically Coadministered P-Glycoprotein Substrates/Modulators. Drug Metabolism and Disposition 37:8, pages 1718-1725.
Crossref
Suresh Katragadda, Sriram Gunda, Sudharshan Hariharan & Ashim K. Mitra. (2008) Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: Evaluation of their utility in treating ocular HSV infections. International Journal of Pharmaceutics 359:1-2, pages 15-24.
Crossref
Tadhg P. BegleyZhong Zuo & Vincent H. L. Lee. 2007. Wiley Encyclopedia of Chemical Biology. Wiley Encyclopedia of Chemical Biology
1
10
.
Mayssa Attar & Jie Shen. 2008. Ocular Transporters In Ophthalmic Diseases And Drug Delivery. Ocular Transporters In Ophthalmic Diseases And Drug Delivery
375
397
.
Banmeet S. Anand, Suresh Katragadda, Sriram Gunda & Ashim K. Mitra. (2006) In Vivo Ocular Pharmacokinetics of Acyclovir Dipeptide Ester Prodrugs by Microdialysis in Rabbits. Molecular Pharmaceutics 3:4, pages 431-440.
Crossref
Shunmugaperumal Tamilvanan & Simon Benita. (2004) The potential of lipid emulsion for ocular delivery of lipophilic drugs. European Journal of Pharmaceutics and Biopharmaceutics 58:2, pages 357-368.
Crossref